Neural Mobilization in the Treatment of Chronic Musculoskeletal Pain in Older Adults: A Single-Case Experimental Design Study.
试验速览
- 阶段
- 不适用
- 状态
- 进行中(未招募)
- 发起方
- 入组人数
- 4
- 试验地点
- 1
- 主要终点
- Pain diary
研究概览
简要总结
The goal of this clinical trial is to discover whether performing active neural mobilization exercises works to manage chronic musculoskeletal pain in older adults. The main question it aims to answer is:
Can an active neural mobilization program improve pain intensity and functional capacity?
Participants will:
- Perform active neural mobilization exercises for 8 weeks (twice a week), under the in-person supervision of a physiotherapist;
- Visit the clinic twice a week for 9 to 12 weeks for consultations, examinations, and symptom monitoring;
- Keep a diary of their symptoms and frequency of analgesic use.
研究设计
- 研究类型
- Interventional
- 分配方式
- Na
- 干预模型
- Single Group
- 主要目的
- Treatment
- 盲法
- None
入排标准
- 年龄范围
- 60 Years 至 —(Adult, Older Adult)
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •Community-dwelling older adults aged 60 years or older
- •People with chronic musculoskeletal pain
排除标准
- •Individuals undergoing surgery in the last 3 months
- •Individuals diagnosed with dementia, cancer, thrombosis, or central nervous system injury (e.g., stroke);
- •Individuals who are receiving another physiotherapy intervention
- •Individuals who do not understand the Portuguese language
- •Individuals with mild cognitive impairment
研究组 & 干预措施
Active Neural Mobilization Exercises
干预措施: Active Neural Mobilization Exercises (Other)
结局指标
主要结局
Pain diary
时间窗: Every day (until the end of the study) - from week 1 to week 21
Participants will be asked to complete a daily "pain diary," recording: * Average pain intensity that day (numerical scale from 0 to 10, where 0 represents "no pain" and 10 represents "the worst pain imaginable"); * Pain-related interference that day (numerical scale from 0 to 10, where 0 represents "no interference" and 10 represents "maximum interference"); * Medication used for pain.
Pain diary
时间窗: Every day (until the end of the study) - from week 1 to week 24
Participants will be asked to complete a daily "pain diary," recording: * Average pain intensity that day (numerical scale from 0 to 10, where 0 represents "no pain" and 10 represents "the worst pain imaginable"); * Pain-related interference that day (numerical scale from 0 to 10, where 0 represents "no interference" and 10 represents "maximum interference"); * Medication used for pain.
次要结局
- Pain distribution(Three assessment points: 1) Baseline 2) At the end of the intervention program 3) At the end of the study (week 21))
- Neuropathic pain components(Three assessment points: 1) Baseline 2) At the end of the intervention program 3) At the end of the study (week 21))
- Pain Catastrophizing(Three assessment points: 1) Baseline 2) At the end of the intervention program 3) At the end of the study (week 21))
- Kinesiophobia(Three assessment points: 1) Baseline 2) At the end of the intervention program 3) At the end of the study (week 21))
- Signs and symptoms of hypersensitivity of the nervous system(Three assessment points: 1) Baseline 2) At the end of the intervention program 3) At the end of the study (week 21))
- Balance(Three assessment points: 1) Baseline 2) At the end of the intervention program 3) At the end of the study (week 21))
- Lower Limb Strength(Three assessment points: 1) Baseline 2) At the end of the intervention program 3) At the end of the study (week 21))
- Grip Strength(Three assessment points: 1) Baseline 2) At the end of the intervention program 3) At the end of the study (week 21))
- Range of motion of wrist extension and tibiotarsal movements(Measured from week 1 to week 9-12 (twice a week). Considering that participants will have different baseline durations and the same intervention duration (8 weeks), the assessment of this outcome can be done up to week 9, 10, 11, or 12.)
- Excursion of the median and fibular nerves(Measured from week 1 to week 9-12 (twice a week). Considering that participants will have different baseline durations and the same intervention duration (8 weeks), the assessment of this outcome can be done up to week 9, 10, 11, or 12.)
- Pressure Pain Threshold measured in three different sites (thenar region of the hand; dorsum of foot; region of greatest pain)(Measured from week 1 to week 9-12 (twice a week). Considering that participants will have different baseline durations and the same intervention duration (8 weeks), the assessment of this outcome can be done up to week 9, 10, 11, or 12.)
- Q-sense - Cold and Warm Perception Threshold (thenar region of the hand; dorsum of foot; region of greatest pain)(Measured from week 1 to week 9-12 (twice a week). Considering that participants will have different baseline durations and the same intervention duration (8 weeks), the assessment of this outcome can be done up to week 9, 10, 11, or 12.)
- Q-sense - Heat Pain Threshold (thenar region of the hand; dorsum of foot; region of greatest pain)(Measured from week 1 to week 9-12 (twice a week). Considering that participants will have different baseline durations and the same intervention duration (8 weeks), the assessment of this outcome can be done up to week 9, 10, 11, or 12.)
- Pain distribution(Three assessment points: 1) Baseline 2) After the 8-week intervention program 3) At the end of the study (week 24))
- Neuropathic pain components(Three assessment points: 1) Baseline 2) After the 8-week intervention program 3) At the end of the study (week 24))
- Pain Catastrophizing(Three assessment points: 1) Baseline 2) After the 8-week intervention program 3) At the end of the study (week 24))
- Kinesiophobia(Three assessment points: 1) Baseline 2) After the 8-week intervention program 3) At the end of the study (week 24))
- Signs and symptoms of hypersensitivity of the nervous system(Three assessment points: 1) Baseline 2) After the 8-week intervention program 3) At the end of the study (week 24))
- Balance(Three assessment points: 1) Baseline 2) After the 8-week intervention program 3) At the end of the study (week 24))
- Lower Limb Strength(Three assessment points: 1) Baseline 2) After the 8-week intervention program 3) At the end of the study (week 24))
- Grip Strength(Three assessment points: 1) Baseline 2) After the 8-week intervention program 3) At the end of the study (week 24))
- Range of motion of wrist extension and tibiotarsal movements(Measured from week 1 to week 12 (twice a week))
- Excursion of the median and fibular nerves(Measured from week 1 to week 12 (twice a week))
- Pressure Pain Threshold measured in three different sites (thenar region of the hand; dorsum of foot; region of greatest pain)(Measured from week 1 to week 12 (twice a week))
- Q-sense - Cold and Warm Perception Threshold (thenar region of the hand; dorsum of foot; region of greatest pain)(Measured from week 1 to week 12 (twice a week))
- Q-sense - Heat Pain Threshold (thenar region of the hand; dorsum of foot; region of greatest pain)(Measured from week 1 to week 12 (twice a week))
研究者
Frederico Mesquita Baptista
Principal Investigator
Aveiro University
